Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Frailty is an age-related decline in physical, socio-psychological and cognitive function resulting in extreme vulnerability to stressors. In patients with cardiovascular disease (CVD) it remains to be elucidated which tests to select to detect/establish frailty in a comprehensive, valid and feasible manner. Purpose 1) To compare the frailty prevalence rates using Fried vs. the more comprehensive Vigorito criteria in CVD patients; 2) To establish which tests, from the physical, socio-psychological and cognitive domains, should be selected to be able to detect frailty in patients with CVD; 3) To establish a total score that may represent a valid measurement of frailty severity, and 4) To examine the association of frailty with long-term clinical outcomes. Methods Patients (n = 133, mean age 78 ± 7 years) hospitalised for coronary revascularisation or heart failure (HF) were examined by the Fried and Vigorito criteria (Mini Nutritional Assessment (MNA), Katz-scale, 4.6m gait speed, timed up-and-go test (TUG), handgrip strength, Mini Mental State Examination (MMSE), Geriatric Depression Scale (GDS-15), number of medications). Additionally, physical activity, time spent sitting, knee extension and hip flexor muscle strength, timed chair-stand test and fear of falling were measured. Multivariate regression and sensitivity/specificity analyses were performed to assess which tests to adopt to detect frailty in CVD patients. Moreover, hospitalisations and mortality, up to six months after the initial hospital admission were examined. Results Any level of frailty was detected in 44% of the patients by the Vigorito criteria and in 65% of the patients by the Fried criteria. However, frailty state may have been overestimated by Fried score as 20% of patients classified as non-frail by Vigorito, were pre-frail by Fried. Furthermore, 10% vs. 38%, respectively, were classified as moderate-frail (by Vigorito) vs. frail (by Fried). Frailty could best be detected (at the earliest stage) by a score from: sex, MNA, Katz-scale, TUG, handgrip strength, MMSE, GDS-15, total number of medications (cut-off score ≥5.56: sensitivity: 1.0, specificity: 0.54, correlation with Vigorito score: r = 0.98, p < 0.001). During the six-month follow-up period, 39% of the patients were readmitted to the hospital (56% of these hospitalisations were attributed to the HF patients) and 7% of the subjects died (89% of them were HF patients). Frailty and specific markers of frailty were significantly associated with mortality and six-month general, urgent, orthopaedic and cardiovascular hospitalisations. Conclusions To detect frailty in patients with CVD, even at an earliest stage, sex, MNA, Katz-scale, TUG, handgrip strength, MMSE, GDS-15 and total number of medications play a key role, assessed by a new time- and cost-efficient test battery for frailty.

Acceptability and utility of a broad test battery to evaluate physical functioning and frailty in community-based settings for people experiencing homelessness and addiction-Findings from the LEAP trials.

Impact of a low-threshold exercise and protein supplementation intervention to optimise physical function and target frailty in people experiencing homelessness and addiction: The LEAP II trial.

Outcomes of the LEAP feasibility trial-A low-threshold, exercise programme with protein supplementation to target frailty and poor physical functioning in people experiencing homelessness and addiction issues

The importance of different frailty domains in a population based sample in England

Removing environmental barriers to independent living: A feasibility randomised controlled trial targeting people ageing with long-term physical disabilities

A Mixed Methods Feasibility Study of Machine-Based Resistance Training With Prefrail Older Adults in Residential Care: The Keeping Active in Residential Elderly Trial II

Reliability and Responsiveness of Two Physical Performance Measures Examined in the Context of a Functional Training Intervention

Development of a comprehensive frailty test battery including physical, socio-psychological and cognitive domains for patients with cardiovascular disease

Prevalence, risks and outcomes of frailty in People Experiencing Homelessness: a protocol for secondary analysis of Health Needs Audit data

Common Physical Performance Tests for Evaluating Health in Older Adults: Cross-Sectional Study

Evaluation of frailty in geriatric patients undergoing cardiac rehabilitation after cardiac procedure: results of a prospective, cross-sectional study

Factors associated with lower quarter performance-based balance and strength tests: a cross-sectional analysis from the project baseline health study

1947 Process evaluation of a home-based intervention to promote independence among older people living with mild frailty

Clinical and cost-effectiveness of a personalised health promotion intervention enabling independence in older people with mild frailty ('HomeHealth') compared to treatment as usual: study protocol for a randomised controlled trial

ASSESSING FRAILTY USING THE FIT-FRAILTY APP IN A NONGERIATRIC PRACTICE: A FEASIBILITY STUDY

The impact of an exercise intervention using low-cost equipment on functional fitness in the community-dwelling older adults: A pilot study

The prevalence and health consequences of frailty in a population-based older home care cohort: a comparison of different measures

Ability of Heart Rate Recovery and Gait Kinetics in a Single Wearable to Predict Frailty: Quasiexperimental Pilot Study

A Non-Controlled Study of a Multi-Factorial Exercise and Nutritional Intervention to Improve Functional Performance and Prevent Frailty Progression in Community-Dwelling Pre-Frail Older Adults.

Reliability in novel field-based fitness measurements and post-exercise scores from a physical fitness test battery in older adults

Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis